Bifogade filer
PDF
Beskrivning
| Land | Finland |
|---|---|
| Lista | Spotlight |
| Sektor | Handel & varor |
| Industri | Detaljhandel |
Following up the success this week, Eevia Health invites shareholders, investors and stakeholders to two more investor webinars. The webinars provide an update on Eevia's strategic reorientation and the current rights issue. The webinars will take place digitally via Microsoft TEAMS on Monday February 10 at 14:00 CET and Friday February 14, 2025, at 09:00 CET.
Following the success this week, Eevia Health invites shareholders, investors and stakeholders to digital webinars. At the webinars, Eevia Health will update on its strategic reorientation, turnaround plan and the rights issue including a broader funding strategy and roadmap.
The webinar will be hosted by CEO Stein Ulve , CTO Petri Lackman and Commercial Director Erik Eide.
To sign up for the webinars and to ask questions in advance, use the link below:
EEVIA INVESTOR WEBINAR #3 - MONDAY, FEBRUARY 10, 2025 AT 14:00 CET:
Link to webinar registration: https://shorturl.at/ANVIl
EEVIA INVESTOR WEBINAR #4 - FRIDAY, FEBRUARY 14, 2025 AT 09:00 CET:
Link to webinar registration: https://shorturl.at/jSjnT
If there are any issue with the links, please email us at: investor@eeviahealth.com
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
Information about Eevia Health Plc
Eevia Health Plc, founded in March 2017, addresses global health challenges with bioactive compounds sustainably extracted from renewable plant materials, with a focus on gut and related health areas, including kidney and urinary health.
Eevia Health is a manufacturer of 100% organically certified plant extracts. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
As a pioneering company Eevia is developing biomaterials that may have dramatic impact on human health. Eevia Health operates a modern green-chemistry production facility in Finland with a short value chain and environmentally friendly carbon footprint. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.